Bioprogress Technology Ltd. operates as a specialty pharmaceutical and over-the-counter (OTC) product company. The company uses its XGEL polymer technologies to develop and enhance medicines and healthcare products. Bioprogress Technology Ltd. is based in Cambridge, United Kingdom. Bioprogress Technology Ltd. was a subsidiary of Meldex International Plc. Meldex International Plc was a publicly traded, specialty pharmaceutical and healthcare business that had sales and marketing infrastructure in the UK, France and USA; product development in the UK and USA and a product portfolio of branded and generic pharmaceutical and healthcare products in France, UK and US. Meldex International plc was placed into Administration on 23 September 2010. Pursuant to paragraph 45 of Schedule B1 of the Insolvency Act 1986 the Joint Administrators Chris McKay and Andrew McTear are managing the affairs, business and property of the above company.

Acquired Companies: Segix Farma S.R.L., Dexo S.A., AquaFilm LLC